{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Electrocorticographic Monitoring in Severe Traumatic Brain Injury"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "randomised 1:1 to either standard care or a tiered intervention protocol"
      },
      "Participants": {
        "score": 2,
        "evidence": "Conducted in an intensive care setting, this randomised controlled trial included patients undergoing surgery for severe TBI with subdural electrode placement."
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised 1:1 to either standard care or a tiered intervention protocol aimed at SD suppression."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study assesses the feasibility and efficacy of a treatment protocol guided by electrocorticographic monitoring of SDs."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the reduction in secondary injury over a 10-day period."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, with allocation concealment via sealed envelopes."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Outcome assessors were blinded to group assignments."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 200 participants were randomised: 100 to the intervention group and 100 to the control group, recruited between January 2020 and June 2021."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis included 98 participants in the intervention group and 97 in the control group, following an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The intervention group demonstrated a significant reduction in secondary injury (mean difference = 5.2, 95% CI 3.1 to 7.3; p = 0.01)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events occurred in 3% of the intervention group and 1% of the control group, with no severe complications reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 20,
    "max_score": 25
  },
  "model": "gpt-4o"
}